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Recent years have seen an explosion of new knowledge de-
fining the molecular events that are critical for development 
and activation of immune cells. Much of this new information 
has come from a careful molecular dissection of key signal 
transduction pathways that are initiated when immune cell 
receptors are engaged. In addition to the receptors them-
selves and critical effector molecules, these signaling path-
ways depend on adapters, proteins that have no intrinsic ef-
fector function but serve instead as scaffolds to nucleate 
multimolecular complexes. This review summarizes some of 
what has been learned about one such adapter protein, SH2 
domain-containing leukocyte phosphoprotein of 76 kDa 
(SLP-76), and how it regulates and integrates signals after 
engagement of immunoreceptors and integrins on various 
immune cell lineages.
[Immune Network 2009;9(3):75-83]
In the  last  twenty-five years,  since the  initial description of 
the  molecular  components  of  the  T  cell  antigen  receptor 
(TCR),  much  attention  has  been  focused  on  understanding 
the biochemical events that occur when that receptor is en-
gaged  by  antigen  (1).  Elegant  work  by  a  number  of  labo-
ratories  showed  that  the  most  proximal  signal  that  initiates 
TCR-induced responses is activation of a cascade of protein 
tyrosine kinases (PTKs)(2,3), first members of the Src family, 
t h e n  t h e  S y k  f a m i l y  P T K  ζ- a s s o c i a t e d  p r o t e i n  o f  7 0  k D a  
(Zap-70),  followed  by  activation  of  members  of  the  Tec 
family. These PTKs then phosphorylate numerous substrates 
leading to the stimulation of multiple second messengers. The 
signal transduction cascades are then integrated in the cell, 
leading to the appropriate biologic response. As the various 
signaling pathways were being defined, a series of studies be-
gan investigating how this critical integration occurred. This 
work led to the identification of a number of adapter pro-
teins. These molecules act as scaffolds, which through their 
modular domains are able to bind a discrete number of other 
molecules, thus creating and appropriately positioning within 
the  cell  complexes  of  signaling  molecules  (4).  Subsequent 
studies demonstrated that this model for adapter protein func-
tion is not restricted to signaling downstream of the TCR, as 
these adapters (or closely related molecules) are found in all 
immune cell lineages and appear essential for supporting the 
function  of  multiple  immunoreceptors,  including  the  B  cell 
antigen  receptor  and  receptors  for  various  immunoglobulin 
constant  regions.  More  recently,  it  has  been  shown  that  a 
subset of these adapters are also critical for signaling down-
stream of other key immune cell receptors, including costimula-
tory  receptors  and  various  adhesion  molecules  including 
integrins. Interestingly, it appears that the molecular rules for how 
these  adapter  proteins  function  overlap  but  are  not  identical.
SRC HOMOLOGY 2 (SH2) DOMAIN-CONTAINING 
LEUKOCYTE PHOSPHOPROTEIN OF 76 kDa 
(SLP-76)
SLP-76 was identified originally in a screen designed to dis-
cover substrates of the PTKs stimulated by ligation of the TCR The Role of SLP-76 in Immune Cells
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(5). The gene encoding SLP-76 had not been previously stud-
ied, and upon initial sequence analysis it appeared likely that 
S L P - 7 6  f u n c t i o n e d  a s  a n  a d a p t e r ,  a s  i t  c o n s i s t e d  o f  s e v e r a l  
modular  domains,  each  with  the  capability  to  bind  other 
p r o t e i n s .  B y  R N A  a n d  p r o t e i n  a n a l y s i s ,  i t  w a s  s h o w n  t h a t  
SLP-76 is present in all hematopoietic lineages, except for ma-
ture  B  cells  (6).  In  its  N-terminal  region,  SLP-76  possesses 
three tyrosine residues (Y112, Y128, and Y145) demonstrated 
to be substrates of syk family PTKs (ZAP-70 in T cells and 
Syk in other immune cell types) (7). Each of these tyrosines 
is in a consensus motif that predicts binding to SH2 domains 
of other proteins. C-terminal to the phosphorylatable tyrosines 
is a proline-rich region that is predicted to bind Src homology 
3 (SH3) domains of other proteins, and at its most C-terminus, 
SLP-76 possesses an SH2 domain that is able to bind other 
proteins,  following  their  own  tyrosine  phosphorylation. 
    Work  from  several  laboratories  has  defined  the  binding 
partners for these three SLP-76 domains. Tyrosines 112 and 
128 are in the same motif (DYESP) and when phosphorylated 
create an excellent docking site for the SH2 domains of the 
guanine nucleotide exchange factor Vav and the adapter pro-
tein  Nck  (8-12).  Phosphorylated  tyrosine  145,  in  a  DYEPP 
motif, is an excellent binder of the SH2 domain of Tec family 
PTKs (13,14). The proline-rich central region of SLP-76 has 
residues that also bind to Tec family PTKs (SH3 domains of 
these molecules) as well as residues that interact with phos-
pholipase Cγ (either γ1 or γ2 depending on the cell line-
age) (15). The central region of SLP-76 also binds to members 
of the Grb2 family of adapter proteins, however with a much 
greater  preference  for  Gads  over  Grb2  itself  (16-18).  The 
C-terminal SLP-76 SH2 domain binds the serine/threonine kin-
ase HPK-1 (19) as well as the adapter protein adhesion and 
degranulation-  promoting  adapter  protein  (ADAP)  (20,21).
    SLP-76 is found in the cytosol of resting cells. It constitu-
tively  binds  to  its  partners  that  interact  via  its  central  pro-
line-rich  region, and it inducibly  associates with its binders 
that require tyrosine phosphorylation after receptor engage-
ment  (and  activation  of  the  receptor-associated  PTKs).  The 
ability of SLP-76 to support signaling downstream of both im-
munoreceptors and integrins appears to require its relocaliza-
tion from the cytosol to signaling clusters that form near the 
activated receptors (22,23). Our current understanding of how 
S L P - 7 6  t r a f f i c s  w i t h i n  c e l l s  i s  d e s c r i b e d  b e l o w .
THE ROLE OF SLP-76 IN T CELL DEVELOPMENT 
AND PERIPHERAL T CELL ACTIVATION
As an adapter protein, it was initially hypothesized that SLP-76 
would serve to increase the efficiency of signaling via cell sur-
face receptors by bringing key components of the signaling 
pathways  together  in  the  right  location  within  the  cell. 
Support for this notion came from initial studies in the Jurkat 
cell  line  model,  where  SLP-76  was  overexpressed  by  gene 
transfection and shown to increase readouts of activation fol-
lowing engagement of the TCR (24). Subsequent studies mak-
ing use of Jurkat cells lacking SLP-76 (25) or mice made defi-
cient in the adapter through gene targeting (26,27) revealed 
the essential role SLP-76 plays in TCR signaling. In both of 
these  model  systems,  it  was  shown  that  in  the  absence  of 
SLP-76, engagement of the TCR still activates Src and Syk fam-
ily  PTKs;  however,  all  PTK-dependent  downstream  signals 
are abrogated. These findings led to the notion that SLP-76, 
through its basal and inducible interactions with other pro-
teins, nucleates a multimolecular complex that is essential for 
TCR signal transduction. The in vivo consequence of SLP-76 
loss in the T cell compartment is a complete block in thymo-
cyte development at the double negative 3 (DN3) stage, the 
point during which the pre-TCR must signal its successful ex-
pression following TCR gene recombination. Failed signaling 
a t  t h i s  p o i n t  l e a d s  t o  t h y m o c y t e  d e a t h  a n d  t h e  a b s e n c e  o f  
double positive (DP) and single positive (SP) cells. Mice lack-
ing SLP-76 therefore have no T cells in their peripheral lym-
phoid  organs.  More  recent  studies  making  use  of  "floxed" 
SLP-76 alleles demonstrate that if the gene for SLP-76 is not 
deleted until after DP thymocytes appear, SLP-76 loss in this 
compartment abrogates selection, leading to thymocyte "death 
by neglect" (28). Deletion of the SLP-76 gene later on in de-
velopment (after T cells have matured and populated the pe-
r i p h e r y )  l e a d s  t o  f a i l e d  T  c e l l  a c t i v a t i o n  f o l l o w i n g  a n t i g e n /  
MHC  encounter  (Maltzman  J,  Personal  Communication).
CONSEQUENCES OF SLP-76 LOSS IN NON-T CELL 
COMPARTMENTS
Examination of SLP-76-deficient animals has revealed critical 
roles for this adapter in multiple other cell lineages, although 
these  cell  types  appear  in  normal  numbers  in  SLP-76-null 
mice. Neutrophils lacking SLP-76 signal poorly through their 
F c  r e c e p t o r s  a n d  c e l l  s u r f a c e  i n t e g r i n s  ( 2 9 ) .  T h i s  r e s u l t s  i n  
diminished adherence and spreading of neutrophils following The Role of SLP-76 in Immune Cells
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integrin  engagement  and  reduced  neutrophil  degranulation 
when  either  Fc  receptors  or  integrins  are  ligated.  Although 
SLP-76-deficient neutrophils are still able to phagocytose and 
kill bacteria, lack of this adapter protein results in diminished 
in vivo inflammatory responses. Mast cells similarly rely on 
SLP-76 for their function, as engagement of the high affinity 
receptor for IgE fails to initiate the appropriate downstream 
biochemical signals when SLP-76 is missing. This defect re-
sults  in  diminished  cytokine  production  and  failed  in  vivo 
passive  systemic  anaphylaxis  (30,31).
    Another cell type that requires SLP-76 for both immunor-
eceptor (Fc receptor) and integrin signaling is platelets. Lack 
of  SLP-76  results  in  failed  platelet  aggregation  or  de-
granulation in response to collagen (which makes use of both 
integrins and the GPVI receptor that pairs with the common 
γ chain of Fc receptors) (32). SLP-76-deficient platelets addi-
tionally  fail  to  transduce  signals  when  stimulated  by  fibri-
nogen  via  the  α2bβ3  receptor  (33).
    Additional studies of SLP-76-deficient mice revealed anoth-
er  striking  phenotype  that  emerged  in  the  absence  of  this 
adapter protein during early development. The initial analysis 
of SLP-76-deficient mice revealed non-Mendelian inheritance 
of  homozygous  null  alleles  in  the  adult  population. 
Subsequent  analysis  demonstrated  that  SLP-76  deficiency  is 
p r e s e n t  i n  a  M e n d e l i a n  r a t i o  u n t i l  s h o r t l y  a f t e r  b i r t h .  
Evaluation of fetuses from SLP-76
＋/− matings gave rise to the 
observation that it was possible to genotype the SLP-76 defi-
ciency by eye, as fetuses lacking two SLP-76 alleles appeared 
grossly hemorrhagic. Later, it was shown that what originally 
appeared as bleeding was in fact the presence of blood-filled 
lymphatic vessels, as it was learned that loss of SLP-76 pre-
vented  normal  separation  of  blood  from  lymphatic  vessels 
(34).  This  defect  leads  to  altered  hemodynamics  of  the 
SLP-76-deficient mice resulting in premature death. The mo-
lecular underpinning of this defect and the signaling pathway 
that  is  causal  remain  under  investigation  (35).
A MODEL FOR HOW SLP-76 SUPPORTS 
IMMUNORECEPTOR SIGNALING
Studies from multiple laboratories have resulted in a wealth 
of data addressing the molecular mechanism by which SLP-76 
integrates signals from cell surface receptors. In resting cells, 
SLP-76  resides  in  the  cytosol,  constitutively  associated  with 
Gads, a member of the Grb2 family of adapters. When im-
munoreceptors are engaged, the most proximal biochemical 
event that occurs is the activation of members of the Src fam-
ily PTKs. This results in the phosphorylation of the immunor-
eceptor tyrosine-based activation motifs (ITAMs) present with-
in the CD3 molecules of the TCR on T cells and Fc receptors 
on other immune cells. The ITAM phosphotyrosines then re-
cruit  members  of  the  Syk  family  PTKs,  thus  converting  the 
immunoreceptor from an enzymatically inert structure to a re-
ceptor  with  associated  PTK  activity. 
    Among  the substrates  that  are  rapidly  phosphorylated  by 
the activated immunoreceptor complex are adapters including 
the transmembrane protein linker of activated T cells (LAT) 
(36). LAT acts as an adapter through its cytoplasmic tyrosines 
that are phosphorylated once Syk PTKs are recruited to the 
immunoreceptor  ITAMs.  Once  phosphorylated,  the  LAT  ty-
rosines  are  able  to  bind  key  signaling  molecules  including 
Gads,  which,  through  its  association  with  SLP-76,  brings 
SLP-76 to LAT and into the vicinity of the activated immuno-
receptor. Together,  LAT and SLP-76  nucleate  a  large  multi-
molecular complex that includes many of key enzymes and 
other  effector  molecules  critical  for  immune  cell  activation.
    Because SLP-76 is also a substrate of Syk family PTKs, acti-
vation  of  immunoreceptors  results  in  SLP-76  tyrosine  phos-
phorylation. This occurs on three residues (Y112, Y128, and 
Y145) within the N-terminus of SLP-76. Y112 and Y128 are 
in the appropriate motif to bind to SH2 domains of Vav, a 
guanine nucleotide exchange factor important for cytoskeletal 
reorganization, and Nck, another adapter essential for full im-
mune cell activation. Y145 has a binding site for the SH2 do-
main of Tec family PTKs (ITK in T cells and BTK in other 
immune cells). These PTKs are critical for initiating calcium 
and ras signaling in immune cells by activating PLC (γ1 in 
T cells and γ2 in other immune cells). Initiation of this path-
way  is  facilitated  by  the  interaction  of  SLP-76  with  PLCγ1 
and PLCγ2 via the proline-rich central region of SLP-76. PLC 
localization is further facilitated by the interaction of these en-
zymes  with  phospho-LAT.  The  C-terminal  SH2  domain  of 
SLP-76  also  recruits  key  signaling  molecules,  including  the 
serine/threonine kinase HPK-1. Recent data suggest that HPK-1 
can phosphorylate SLP-76 on serine residues (37). The SLP-76 
SH2  domain  also  interacts  with  another  adapter  protein, 
ADAP,  once  ADAP  is  phosphorylated  by  the  activated  im-
munoreceptor. ADAP is important for linking the immunor-
eceptor  activation  complex  with  integrins  (see  below).
    Evidence  supporting  the  inducible  creation  of  this  multi-
molecular  signaling  complex  has  come  from  biochemical, 
imaging, and genetic approaches using cell lines and in vivo The Role of SLP-76 in Immune Cells
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model systems. Early studies defined the binding partners of 
LAT and SLP-76, and then mapped residues key for these in-
teractions using cell lines lacking either molecule followed by 
transfection of wild type or mutant versions of LAT (38) or 
SLP-76  (16,21,39)  for  subsequent  biochemical  analysis.
    Interestingly,  when  transfected  SLP-76  or  LAT  constructs 
were tagged with fluorochromes and subjected to image anal-
ysis, it was found that immunoreceptor engagement resulted 
in the rapid appearance of microclusters containing the two 
adapter proteins along with other signaling molecules  (22). 
Subsequent studies following the dynamics of these clusters 
in real time in living cells demonstrated that the interaction 
between SLP-76 and LAT via Gads was essential for the nor-
mal  appearance  and  movement  of  these  clusters  (40).
TESTING THE MODEL: THE SLP-76/LAT COMPLEX IS 
CRITICAL FOR IMMUNORECEPTOR SIGNALING
The  demonstration  that  a  large  multimolecular  complex 
nucleated  by  LAT  and  SLP-76  exists  did  not  prove  the  im-
portance  of  this  complex  for  immunoreceptor  function. 
SLP-76- and LAT-deficient cell lines and mice were therefore 
employed to address the causal relationship between the in-
termolecular  interactions,  microcluster  formation,  and  im-
munoreceptor  function.  The  paradigm  for  the  cell  line  ap-
proach  was  to  express  wild  type  or  mutant  SLP-76  or  LAT 
variants in Jurkat cells lacking these proteins (J14 for SLP-76 
and J.CaM2 for LAT) by transfection of cDNAs. For both J14 
and J.CaM2, transfection of cDNA encoding a wild type ver-
sion  of  the  missing  molecule  completely  restored  signaling 
mediated via the TCR. Subsequent studies demonstrated that 
mutants of SLP-76 or LAT that could not bind to Gads failed 
to support TCR-mediated activation of the PLC signaling cas-
cade (23,41-43). Complementary studies were then performed 
in  primary  murine  T  cells  in  which  a  small  peptide  that 
blocked the interaction between SLP-76 and Gads was used 
and  found  to  markedly  interfere  with  TCR  signaling  (44).
  T h e  in vivo importance of the SLP-76/Gads/LAT axis was 
then demonstrated through the use of transgenic animals ex-
pressing SLP-76 mutants on the SLP-76-deficient background 
and through retroviral transduction of SLP-76 null bone mar-
row with wild type or mutant variants of SLP-76 followed by 
transplant  into  Rag
−/−  recipients  (32,45-47).  In  both  cases, 
although  the  phenotype  is  not  as  severe  as  that  seen  with 
t h e  c o m p l e t e  a b s e n c e  o f  S L P - 7 6 ,  e x p r e s s i o n  o f  a  m u t a n t  
SLP-76 molecule that cannot bind to Gads fails to restore nor-
mal T cell development. Thus, while SLP-76 deficiency results 
in a complete block in thymocyte development at the DN3 
s ta g e,  r ec o ns ti tu t io n of  SLP - 76 - de fi ci en t  m ic e w it h  a m u ta nt 
of the adapter that cannot bind Gads allows for the develop-
ment of some DP cells. Few SP thymocytes or peripheral T 
cells emerge, however, in these mice, and those cells that do 
develop fail to respond to TCR engagement. Thus, it appears 
that  some  TCR  function  can  occur  when  SLP-76  cannot  be 
localized to LAT via Gads; however, this function is markedly 
curtailed.  Whether  the  residual  function  is  due  to  an  alter-
native  means  to  relocalize  SLP-76  or  instead  due  to  SLP-76 
functions  elsewhere  in  the  cell  is  under  investigation.
    Generating mice in which SLP-76 is altered so that it no 
longer binds Gads provided the opportunity to investigate the 
importance of the SLP-76/Gads/LAT axis for signaling via im-
munoreceptors in non-T cell lineages and for testing the im-
portance of these intermolecular interactions downstream of 
integrins.  Mast  cells  from  mice  reconstituted  with  a  SLP-76 
mutant that cannot bind Gads signal poorly via their high af-
finity  receptor  for  IgE  (40,48),  and  platelets  expressing  the 
Gads binding mutant in the absence of wild type SLP-76 do 
not respond to collagen via GPVI (32). However, in all line-
ages tested, although SLP-76 is critical for responses to cell 
surface  integrins,  this  SLP-76  function  appears  to  be  in-
dependent  of  the  Gads-binding  region  of  the  adapter  (46). 
T h i s  f i n d i n g  a l o n g  w i t h  s t u d i e s  s u g g e s t i n g  t h a t  L A T  i s  d i s -
pensable  for  integrin  signaling  indicate  that  the  molecular 
complexes nucleated by SLP-76 differ between these signaling 
pathways. 
THE ROLE OF THE SLP-76 SH2 DOMAIN IN 
SIGNALING FROM IMMUNORECEPTORS TO 
INTEGRINS
One important consequence of immunoreceptor signaling is 
to upregulate the avidity of integrins for their ligands (a proc-
ess  known  as  "inside-out"  signaling),  thus  making  immune 
cells better able to respond to integrin activation (49). Several 
laboratories have investigated the molecular basis and, in par-
t i c u l a r ,  t h e  d o m a i n s  o f  S L P - 7 6  t h a t  a r e  m o s t  c r i t i c a l  f o r  i n-
side-out  signaling.  This  work  led  to  the  finding  that  the 
SLP-76 SH2 domain, while dispensable for coupling the TCR 
to a number of its second messenger cascades (for example, 
the PLC pathway), appears critical for inside-out signaling. A 
molecular  explanation  for  this  finding  was  provided  by  an 
a n a l y s i s  o f  A D A P ,  o n e  o f  t h e  m o l e c u l e s  t h a t  i n t e r a c t s  w i t h The Role of SLP-76 in Immune Cells
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the  SLP-76  SH2  domain. 
    ADAP  becomes  tyrosine  phosphorylated  following  im-
munoreceptor  engagement  by  Fyn,  one  of  the  Src  family 
PTKs that is inducibly activated upon TCR engagement (20). 
In fact, ADAP can also associate with Fyn in a large molecular 
complex. Dissection of this Fyn-associated complex led to the 
discovery  of  another  adapter  molecule  designated  SKAP55 
(Src kinase-associated adapter protein of 55 kDa) (50). SKAP55 
binds constitutively to a proline-rich region of ADAP via the 
SKAP55 SH3 domain  (51). Interestingly, it appears  that not 
only do ADAP and SKAP55 associate with each other but that 
this interaction also is critical for stabilizing ADAP expression, 
as  loss  of  SKAP55  results  in  rapid  degradation  of  ADAP  in 
the  cell  (52).
    After the discovery of ADAP and SKAP55, a series of stud-
ies were initiated to probe their importance in immune cell 
signaling. Several groups found that cells lacking these adapt-
er proteins failed to adhere tightly to integrin coated surfaces 
(53-55).  This  was  found  to  be  due  to  defects  in  both  in-
side-out  signaling  from  immunoreceptors  to  integrins  (thus 
decreasing integrin avidity for ligand) and also to diminished 
outside-in  signaling  from  integrins  into  the  cell.  These  ob-
servations, however, did not address how SLP-76, ADAP, and 
SKAP55 were able to intersect with integrins within the cell. 
A candidate for linking ADAP and SKAP55 to integrins came 
w it h t h e d is co v er y o f y e t a no t he r a da pt er  mo le c ul e k no w n 
as  RIAM  (Rap1-GTP-interacting  adapter  molecule)  (56). 
Interest in RIAM as a potential linker was piqued by the find-
i n g  t h a t  R I A M  a s s o c i a t e s  w i t h  t h e  a c t i v e  f o r m  o f  t h e  s m a l l  
molecular  weight  GTPase  Rap1  (57).  Several  earlier  studies 
had  shown  that  active Rap1 played  an  essential  role  in in-
side-out  signaling  to  integrins  (58-61).  How  these  pieces 
might all fit together was suggested by the finding that RIAM 
also binds to SKAP55 (62). Collectively, these studies result 
i n  a  m o d e l  s u g g e s t i n g  t h a t  s t i m u l a t i o n  o f  i m m u n o r e c e p t o r s  
results  in  another  large  SLP-76-nucleated  complex,  this  one 
centered  around  the  SLP-76  SH2  domain  containing  ADAP, 
SKAP55,  RIAM,  and  activated  Rap1.  It  is  this  complex  that 
is essential for linking immunoreceptors to upregulation of in-
tegrin functions. It remains to be determined exactly how this 
complex is recruited to integrins and whether this complex 
is built around a SLP-76 molecule that also binds Gads, PLC, 
and LAT, or if the two signaling scaffolds are distinct from 
each  other.
EXPLORING THE IMPORTANCE OF THE SLP-76 
TYROSINES USING GENOMIC KNOCKIN MICE
The first in vivo structure/function studies of SLP-76 making 
use  of  mice  transgenic  for  mutant  forms  of  SLP-76  crossed 
to  SLP-76-deficient  animals  demonstrated  that  among  the 
three SLP-76 protein interacting domains, the N-terminal ty-
r o s i n e s  w e r e  m o s t  c r i t i c a l  f o r  f u n c t i o n  ( 4 5 , 4 7 ) .  T h i s  w a s  
shown using a transgene in which the three N-terminal ty-
rosines were all altered to phenylalanine (Y3F). Although not 
an exact phenocopy of the SLP-76-null mice, each lineage ex-
amined expressing the Y3F variant of SLP76 signaled poorly 
via immunoreceptors and integrins. Subsequent studies made 
use  of  the  J14  cell  line  by  transfecting  constructs  encoding 
wild  type  SLP-76  or  mutant  variants  of  SLP-76  where  one, 
two, or all three tyrosines were altered to phenylalanine (63). 
Every  combination  was  studied  leading  to  the  observation 
that Y145 seemed most critical for TCR function and that the 
combination  of  Y112  and  Y128  altered  to  phenylalanine 
seemed to have the next most significant effect. Thus, in J14 
cells expressing either the Y145F or Y112/128F mutant, en-
gagement  of  the  TCR  couples  poorly  with  the  downstream 
signaling pathways described above. These data as well as 
the fact that Y112 and Y128 are found in the same DYESP 
motif while Y145 is present within a slightly different DYEPP 
m o t i f  l e d  u s  t o  g e n e r a t e  g e n o m i c  k n o c k i n  m i c e  i n  w h i c h  
Y145  or  both  Y112  and  Y128  of  SLP-76  were  altered  to 
phenylalanine.  These mice made it possible to explore the 
in  vivo  consequences  of  these  mutations  (64,65).
    The first observation made with the knockin animals was 
that  the  perinatal  lethality  found  in  SLP-76-null  animals  is 
rescued. This finding suggests that although immunoreceptor 
and integrin signaling (see below) are severely compromised 
in these mice, sufficient signaling is supported by the SLP-76 
mutants to prevent the vascular abnormalities from occurring. 
This observation provides an important clue that is being pur-
sued to understand what cell type and which receptor on that 
cell requires SLP-76 to support normal vascular development.
  Given the poor signaling via the TCR in the Jurkat system, 
we were surprised to discover that gross thymic development 
in the Y145F and Y112/128F mice was remarkably intact in 
terms  of  overall  cellularity  and  examination  of  subsets  by 
CD4/CD8 staining. It was evident, however, through staining 
for  CD5  and  surface  TCR  levels  that  positive  selection  was 
likely aberrant. This finding was extended by evaluating TCR 
Vβ family  usage  with  the  observation  that  in  strains  that The Role of SLP-76 in Immune Cells
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should have eliminated particular TCR families (due to endog-
enous superantigen expression), deletion was defective (worse 
in the Y145F compared to the Y112/128F mice). Thus, it ap-
peared that both positive and negative selection may be im-
pacted by altering the SLP-76 tyrosines. This was confirmed 
by  breeding  the  knockin  mice  to  animals  expressing  TCR 
transgenes  that  should  either  signal  deletion  or  positive 
selection. In both circumstances we found substantial defects 
in selection, again with the Y145F mice demonstrating a more 
pronounced phenotype than that observed in the Y112/128F 
animals. Aberrant selection in the thymi of these mice corre-
lated with failed TCR signaling as expected from the studies 
of  the  reconstituted  J14  mice.
    Generating knockin mice with complementary tyrosine mu-
tations gave us the opportunity to test the hypothesis that two 
SLP-76  mutants,  each  conferring  a  significant  phenotype, 
could complement each other in trans in a single cell. To ap-
proach this question, we bred the Y145F mice to mice ex-
pressing Y112/128F SLP-76 resulting in animals with no wild 
type  SLP-76  alleles  but  instead  one  Y145F  allele  and  one 
Y112/128F encoding chromosome. We were surprised that in 
every  assay  of  TCR  function  or  thymic  development,  we 
found a rescue to nearly wild type levels. Thus, it appears 
that the two SLP-76 mutants can cooperate with each other 
when  expressed  in  the  same  cell.
    The knockin mice gave us the opportunity also to inves-
tigate the importance of the SLP-76 tyrosines in other lineages. 
Similar to what we discovered in the T cell compartment, pla-
telets expressing either the Y145F or Y112/128F SLP-76 mu-
tants revealed marked signaling abnormalities downstream of 
the  GPVI  receptor  (65).  Interestingly,  while  there  were  de-
fects  in  integrin  signaling  in  platelets  from  both  knockin 
strains, the abnormalities appeared greater in the Y112/128F 
cells compared  to  their  Y145F  counterparts. Because  the  Y 
to F knockin mice did not demonstrate a vascular phenotype, 
we were able to investigate the importance of the tyrosines 
for  in  vivo  platelet  function.  For  these  studies,  we  applied 
an  irritant  (ferric  chloride)  to  the  external  carotid  artery  of 
mice and then measured blood flow in the artery by Doppler. 
In wild type mice, the irritated artery stimulated a rapid plate-
let response resulting in occlusion of the vessel by a stable 
thrombus. The vast majority of SLP-76 Y145F mice failed en-
tirely  to  occlude  the  vessel,  and  in  all  but  one  mouse  in 
w h i c h  a  t h r o m b u s  f o r m e d ,  t h e  c l o t  t h a t  d i d  o c c u r  w a s  
unstable. The phenotype of the Y112/128F mice tended to-
wards  defective  thrombus  formation  but  was  not  nearly  as 
pronounced  as  seen  in  the  Y145F  animals.  Based  on  our 
studies in T cells, we predicted that the two tyrosine mutant 
alleles would complement each other in trans in the platelet 
compartment.  We  were  surprised  to  discover  that  this  was 
not the case, an observation that we are continuing to pursue.
SUMMARY
Recent years have seen an explosion of new knowledge in-
forming  the  scientific  community  regarding  the  process  by 
which signals are transmitted from engaged receptors on the 
s u r f a c e  o f  c e l l s .  I m m u n e  c e l l s  h a v e  p r o v e n  t o  b e  a n  o u t -
standing model system, as they are easily accessible and can 
be manipulated both in vitro  and in vivo. Signals initiated 
by  the binding of immunoreceptors and integrins results in 
the assembly of large multimolecular complexes that are crit-
ical  for  integration  of  the  myriad  of  second  messenger 
cascades.  These  complexes  are  nucleated  by  key  adapter 
proteins. Interestingly, while some of the rules for the gen-
eration  and  function  of  these  complexes  are  the  same,  the 
molecular details of how they act appear to differ between 
cell types and receptor systems. Additional information about 
how  these  complexes  regulate  key  biologic  outcomes  will 
provide useful clues as attempts are made to manipulate sig-
naling  events  for  therapeutic  benefit.
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